The incidence of HIV infections in the United States has remained steady over many years. This cost-effectiveness analysis found that expanding HIV testing and treatment simultaneously was more beneficial and cost-effective in reducing new infections than using either method alone but only modestly decreased new infections. However, halving risk behavior among patients tested and treated markedly decreased the number of new infections. This analysis suggests that substantial reductions in the magnitude of the U.S. HIV epidemic will require a multimodal approach of testing, treatment, and behavior change.
Topics:
hiv, antiretroviral therapy, highly active, cost effectiveness, infection, hiv infection, hiv screen, ...
Ann Intern Med. 2010;153(12):778-789. doi:10.7326/0003-4819-153-12-201012210-00004